Hemophilia screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Simrat}} | {{CMG}}; {{AE}} {{Simrat}} | ||
==Overview== | ==Overview== | ||
Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT) | Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT). Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia. | ||
==Screening== | ==Screening== | ||
*Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT). | *Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT). |
Revision as of 03:44, 13 January 2019
Hemophilia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemophilia screening On the Web |
American Roentgen Ray Society Images of Hemophilia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT). Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia.
Screening
- Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT).
- Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia.